HomeAPVO • NASDAQ
add
Aptevo Therapeutics Inc
Previous close
$1.38
Year range
$1.04 - $298.00
Market cap
23.25M USD
Avg Volume
771.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.61M | 45.98% |
Net income | -7.55M | -47.99% |
Net profit margin | — | — |
Earnings per share | -2.23 | 99.37% |
EBITDA | -7.56M | -47.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.06M | 171.65% |
Total assets | 27.00M | 78.24% |
Total liabilities | 9.60M | -10.46% |
Total equity | 17.39M | — |
Shares outstanding | 16.85M | — |
Price to book | 1.10 | — |
Return on assets | -89.28% | — |
Return on capital | -112.86% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.55M | -47.99% |
Cash from operations | -6.69M | -28.07% |
Cash from investing | — | — |
Cash from financing | 18.34M | 273.58% |
Net change in cash | 11.65M | 3,822.36% |
Free cash flow | -3.90M | -12.85% |
About
Founded
2016
Headquarters
Website
Employees
37
